United Kingdom: Food and Drugs Law

News on advertising less healthy food and drinks just keeps coming — the Food Standards Agency (FSA) in Northern Ireland and the Department of Health are now consulting on introducing restrictions...

This monthly roundup examines critical patent law developments across multiple jurisdictions, including landmark UPC Court of Appeal decisions on preliminary injunctions and urgency requirements, French and Belgian court rulings on supplementary protection certificates and biosimilar equivalence, and UK guidance on expedition applications in pharmaceutical patent disputes. The analysis explores how courts are interpreting infringement standards, evidence production alignment in parallel proceedings, and the

An investigation is underway after multiple sclerosis patients in the UK reported adverse effects following a switch from the originator medicine Tysabri to its biosimilar Tyruko. Despite regulatory approval confirming no clinically meaningful differences between the two natalizumab-based treatments, subtle variations in manufacturing processes, formulation buffers, and molecular characteristics may explain why some patients have experienced worsening symptoms or side effects.

The phrase "clinically proven" is one of the most powerful claims in a beauty marketer's ‘Arsenal’*. It sounds scientific, authoritative, and reassuring. But in a ruling published in April 2026,...

The MHRA’s proposed rare disease therapies regulatory framework (“the Proposed Framework”) represents an ambitious attempt to redesign medicines regulation around the realities of rare disease development.

The MHRA has launched a consultation on proposed updates to the definition of gene therapy medicinal products (“GTMPs”) under the UK Human Medicines Regulations 2012 (“HMRs”).

On 31 March 2026, the UK Government's Department for Business and Trade and the Office for Product Safety and Standards launched a consultation on a proposed new product safety...

As of February 24, 2026, the United Kingdom (UK) government has announced that the interim approaches to adding Substances of Very High Concern (SVHC) to the UK Candidate...

GLP‑1 drugs are driving a seismic shift in how Americans eat - and the U.S. snacking market sits at the epicenter. And it's not surprising why: 2 in 5 adults have obesity, and nearly...